Engineering Microbial Living Therapeutics: The Synthetic Biology Toolbox.

Microbes can be engineered to act like living therapeutics designed to perform specific actions in the human body. From fighting and preventing infections to eliminating tumors and treating metabolic disorders, engineered living systems are the next generation of therapeutics. In recent years, synthetic biologists have greatly expanded the genetic toolbox for microbial living therapeutics, adding sensors, regulators, memory circuits, delivery devices, and kill switches. These advances have paved the way for successful engineering of fully functional living therapeutics, with sensing, production, and biocontainment devices. However, some important tools are still missing from the box. In this review, we cover the most recent biological parts and approaches developed and describe the missing tools needed to build robust living therapeutics.

[1]  Jing Wui Yeoh,et al.  Repurposing a Two-Component System-Based Biosensor for the Killing of Vibrio cholerae. , 2017, ACS synthetic biology.

[2]  C. Mathieu,et al.  Reversal of Diabetes in NOD Mice by Clinical-Grade Proinsulin and IL-10–Secreting Lactococcus lactis in Combination With Low-Dose Anti-CD3 Depends on the Induction of Foxp3-Positive T Cells , 2016, Diabetes.

[3]  B. Strukelj,et al.  Single plasmid systems for inducible dual protein expression and for CRISPR-Cas9/CRISPRi gene regulation in lactic acid bacterium Lactococcus lactis , 2018, Scientific Reports.

[4]  L. Álvarez-Vallina,et al.  Programming Controlled Adhesion of E. coli to Target Surfaces, Cells, and Tumors with Synthetic Adhesins , 2014, ACS synthetic biology.

[5]  K. T. Holland,et al.  Xylan-regulated delivery of human keratinocyte growth factor-2 to the inflamed colon by the human anaerobic commensal bacterium Bacteroides ovatus , 2009, Gut.

[6]  Klaus Ley,et al.  Bacterial colonization factors control specificity and stability of the gut microbiota , 2013, Nature.

[7]  R. Rupprecht,et al.  “I Am I and My Bacterial Circumstances”: Linking Gut Microbiome, Neurodevelopment, and Depression , 2017, Front. Psychiatry.

[8]  Jeffrey J. Tabor,et al.  Engineering Diagnostic and Therapeutic Gut Bacteria , 2017, Microbiology spectrum.

[9]  A. Riazi,et al.  Development of a Stress-Inducible Controlled Expression (SICE) system in Lactococcus lactis for the production and delivery of therapeutic molecules at mucosal surfaces. , 2013, Journal of biotechnology.

[10]  Farren J. Isaacs,et al.  Multilayered genetic safeguards limit growth of microorganisms to defined environments , 2015, Nucleic acids research.

[11]  E. Garcia-Fruitós,et al.  Lactic acid bacteria: reviewing the potential of a promising delivery live vector for biomedical purposes , 2015, Microbial Cell Factories.

[12]  R. Rahim,et al.  A review on Lactococcus lactis: from food to factory , 2017, Microbial Cell Factories.

[13]  P. Silver,et al.  A synthetic bacterial information transfer system functions in the mammalian gut , 2018, bioRxiv.

[14]  A. Maxmen.  Living therapeutics: Scientists genetically modify bacteria to deliver drugs , 2017, Nature Medicine.

[15]  Á. Marcobal,et al.  Expression of Human Immunodeficiency Virus Type 1 Neutralizing Antibody Fragments Using Human Vaginal Lactobacillus , 2016, AIDS research and human retroviruses.

[16]  Jens V. Stein,et al.  The outer mucus layer hosts a distinct intestinal microbial niche , 2015, Nature Communications.

[17]  M. Chang,et al.  Designer probiotics for the prevention and treatment of human diseases. , 2017, Current opinion in chemical biology.

[18]  C. Mackay,et al.  Beyond gut feelings: how the gut microbiota regulates blood pressure , 2018, Nature Reviews Cardiology.

[19]  R. Grabherr,et al.  Tuning constitutive recombinant gene expression in Lactobacillus plantarum , 2014, Microbial Cell Factories.

[20]  Katherine H. Huang,et al.  Structure, Function and Diversity of the Healthy Human Microbiome , 2012, Nature.

[21]  Michael Zimmermann,et al.  Engineered Regulatory Systems Modulate Gene Expression of Human Commensals in the Gut , 2017, Cell.

[22]  Michael A. Fischbach,et al.  Synthetic Microbes As Drug Delivery Systems , 2014, ACS synthetic biology.

[23]  William E Bentley,et al.  Engineered probiotic Escherichia coli can eliminate and prevent Pseudomonas aeruginosa gut infection in animal models , 2017, Nature Communications.

[24]  Chueh Loo Poh,et al.  Reprogramming microbes to be pathogen-seeking killers. , 2014, ACS synthetic biology.

[25]  Ryo Takeuchi,et al.  Biocontainment of genetically modified organisms by synthetic protein design , 2015, Nature.

[26]  T. Dinan,et al.  The microbiota-gut-brain axis in obesity. , 2017, The lancet. Gastroenterology & hepatology.

[27]  Franck Molina,et al.  Detection of pathological biomarkers in human clinical samples via amplifying genetic switches and logic gates , 2015, Science Translational Medicine.

[28]  Yiannis N. Kaznessis,et al.  Modified Lactic Acid Bacteria Detect and Inhibit Multiresistant Enterococci , 2014, ACS synthetic biology.

[29]  P. Saris,et al.  Isolation of strong constitutive promoters from Lactococcus lactis subsp. lactis N8. , 2015, FEMS microbiology letters.

[30]  Adam B Fisher,et al.  Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria , 2018, Nature Biotechnology.

[31]  Timothy K Lu,et al.  Programming a Human Commensal Bacterium, Bacteroides thetaiotaomicron, to Sense and Respond to Stimuli in the Murine Gut Microbiota. , 2015, Cell systems.

[32]  Debra J Wilson,et al.  NIH guidelines for research involving recombinant DNA molecules. , 1993, Accountability in research.

[33]  C. Sarkar,et al.  Nisin‐inducible secretion of a biologically active single‐chain insulin analog by Lactococcus lactis NZ9000 , 2011, Biotechnology and bioengineering.

[34]  Jean Paul Thiery,et al.  Engineered commensal microbes for diet-mediated colorectal-cancer chemoprevention , 2018, Nature Biomedical Engineering.

[35]  Jeong Wook Lee,et al.  Next-generation biocontainment systems for engineered organisms , 2018, Nature Chemical Biology.

[36]  Takashi Sato,et al.  Oral delivery of Lactococcus lactis that secretes bioactive heme oxygenase-1 alleviates development of acute colitis in mice , 2015, Microbial Cell Factories.

[37]  Birbal Singh,et al.  Designer Probiotics: Paving the Way to Living Therapeutics. , 2017, Trends in biotechnology.

[38]  E. Santero,et al.  Engineering Salmonella as intracellular factory for effective killing of tumour cells , 2016, Scientific Reports.

[39]  Audrey Lee-Gosselin,et al.  Tunable thermal bioswitches for in vivo control of microbial therapeutics. , 2017, Nature chemical biology.

[40]  H. M. Nielsen,et al.  Penetratin-Mediated Transepithelial Insulin Permeation: Importance of Cationic Residues and pH for Complexation and Permeation , 2015, The AAPS Journal.

[41]  Philippe Marlière,et al.  Chemical evolution of a bacterium's genome. , 2011, Angewandte Chemie.

[42]  M. Omar Din,et al.  Synchronized cycles of bacterial lysis for in vivo delivery , 2016, Nature.

[43]  James J. Collins,et al.  Probiotic strains detect and suppress cholera in mice , 2018, Science Translational Medicine.

[44]  James J Collins,et al.  Programmable bacteria detect and record an environmental signal in the mammalian gut , 2014, Proceedings of the National Academy of Sciences.

[45]  Finn Stirling,et al.  Rational Design of Evolutionarily Stable Microbial Kill Switches. , 2017, Molecular cell.

[46]  Michael Baym,et al.  Engineered bacteria can function in the mammalian gut long-term as live diagnostics of inflammation , 2017, Nature Biotechnology.

[47]  Jeff Hasty,et al.  Programmable probiotics for detection of cancer in urine , 2015, Science Translational Medicine.

[48]  In Young Hwang,et al.  Reprogramming Probiotic Lactobacillus reuteri as a Biosensor for Staphylococcus aureus Derived AIP-I Detection. , 2018, ACS synthetic biology.

[49]  Weston R. Whitaker,et al.  Tunable Expression Tools Enable Single-Cell Strain Distinction in the Gut Microbiome , 2017, Cell.

[50]  E. Hsiao,et al.  Linking the Gut Microbiota to a Brain Neurotransmitter , 2018, Trends in Neurosciences.

[51]  L. Steidler.  Genetically engineered probiotics. , 2003, Best practice & research. Clinical gastroenterology.

[52]  Ruifeng Mao,et al.  Secretory expression and surface display of a new and biologically active single-chain insulin (SCI-59) analog by lactic acid bacteria , 2017, Applied Microbiology and Biotechnology.

[53]  J. Amar.  Microbiota-Host Crosstalk: A Bridge Between Cardiovascular Risk Factors, Diet, and Cardiovascular Disease. , 2018, American journal of hypertension.

[54]  Christopher A. Voigt,et al.  Targeted DNA degradation using a CRISPR device stably carried in the host genome , 2015, Nature Communications.